Compare Enveric Biosciences Inc (ENVB) vs Inovio Pharmaceuticals Inc (INO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enveric Biosciences Inc vs Inovio Pharmaceuticals Inc — how do they compare? Enveric Biosciences Inc trades at $1.45 (market cap $6.20M), while Inovio Pharmaceuticals Inc trades at $0.73 (market cap $78.55M). The key difference: Inovio Pharmaceuticals Inc is far larger — about 12.7× Enveric Biosciences Inc's market cap. Which is the better fit depends on your goals.
| ENVB | INO | |
|---|---|---|
Market Cap | $6.20M | $78.55M |
Sector | Health | Health |
52-Week High | $17.40 | $2.87 |
52-Week Low | $1.27 | $0.66 |
Enterprise Value | $1.30M | $49.56M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →About Inovio Pharmaceuticals Inc
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →
